Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-13

FDA Approved: ZONISAMIDE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for Zonisamide from BluePoint Laboratories, authorizing a generic version of zonisamide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

SUPPL AP for ZONISAMIDE (ZONISAMIDE)